Literature DB >> 19773443

Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

James C Garbe1, Sanchita Bhattacharya, Batul Merchant, Ekaterina Bassett, Karen Swisshelm, Heidi S Feiler, Andrew J Wyrobek, Martha R Stampfer.   

Abstract

Normal human epithelial cells in culture have generally shown a limited proliferative potential of approximately 10 to 40 population doublings before encountering a stress-associated senescence barrier (stasis) associated with elevated levels of cyclin-dependent kinase inhibitors p16 and/or p21. We now show that simple changes in medium composition can expand the proliferative potential of human mammary epithelial cells (HMEC) initiated as primary cultures to 50 to 60 population doublings followed by p16-positive, senescence-associated beta-galactosidase-positive stasis. We compared the properties of growing and senescent pre-stasis HMEC with growing and senescent post-selection HMEC, that is, cells grown in a serum-free medium that overcame stasis via silencing of p16 expression and that display senescence associated with telomere dysfunction. Cultured pre-stasis populations contained cells expressing markers associated with luminal and myoepithelial HMEC lineages in vivo in contrast to the basal-like phenotype of the post-selection HMEC. Gene transcript and protein expression, DNA damage-associated markers, mean telomere restriction fragment length, and genomic stability differed significantly between HMEC populations at the stasis versus telomere dysfunction senescence barriers. Senescent isogenic fibroblasts showed greater similarity to HMEC at stasis than at telomere dysfunction, although their gene transcript profile was distinct from HMEC at both senescence barriers. These studies support our model of the senescence barriers encountered by cultured HMEC in which the first barrier, stasis, is retinoblastoma-mediated and independent of telomere length, whereas a second barrier (agonescence or crisis) results from telomere attrition leading to telomere dysfunction. Additionally, the ability to maintain long-term growth of genomically stable multilineage pre-stasis HMEC populations can greatly enhance experimentation with normal HMEC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773443      PMCID: PMC2782785          DOI: 10.1158/0008-5472.CAN-09-0270

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

2.  Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells.

Authors:  M R Stampfer; A Bodnar; J Garbe; M Wong; A Pan; B Villeponteau; P Yaswen
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

3.  p16INK4a modulates p53 in primary human mammary epithelial cells.

Authors:  Jianmin Zhang; Curtis R Pickering; Charles R Holst; Mona L Gauthier; Thea D Tlsty
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

4.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program.

Authors:  Yongping G Crawford; Mona L Gauthier; Anita Joubel; Kristin Mantei; Krystyna Kozakiewicz; Cynthia A Afshari; Thea D Tlsty
Journal:  Cancer Cell       Date:  2004-03       Impact factor: 31.743

6.  Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland.

Authors:  A Sapino; L Macrì; L Tonda; G Bussolati
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

7.  Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks.

Authors:  Olga A Sedelnikova; Izumi Horikawa; Drazen B Zimonjic; Nicholas C Popescu; William M Bonner; J Carl Barrett
Journal:  Nat Cell Biol       Date:  2004-02       Impact factor: 28.824

8.  Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract.

Authors:  S L Hammond; R G Ham; M R Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion.

Authors:  Catherine L Olsen; Betty Gardie; Paul Yaswen; Martha R Stampfer
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

10.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation.

Authors:  A J Brenner; M R Stampfer; C M Aldaz
Journal:  Oncogene       Date:  1998-07-16       Impact factor: 9.867

View more
  98 in total

Review 1.  Stem cells in the human breast.

Authors:  Ole William Petersen; Kornelia Polyak
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

2.  Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells.

Authors:  Alireza Delfarah; Sydney Parrish; Jason A Junge; Jesse Yang; Frances Seo; Si Li; John Mac; Pin Wang; Scott E Fraser; Nicholas A Graham
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

3.  Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.

Authors:  Damian J Junk; Rocky Cipriano; Benjamin L Bryson; Hannah L Gilmore; Mark W Jackson
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

4.  Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions.

Authors:  Agostina Nardone; Sara Corvigno; Annalisa Brescia; Daniel D'Andrea; Gennaro Limite; Bianca Maria Veneziani
Journal:  Cytotechnology       Date:  2010-12-28       Impact factor: 2.058

5.  Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state.

Authors:  Christine L Chaffer; Ines Brueckmann; Christina Scheel; Alicia J Kaestli; Paul A Wiggins; Leonardo O Rodrigues; Mary Brooks; Ferenc Reinhardt; Ying Su; Kornelia Polyak; Lisa M Arendt; Charlotte Kuperwasser; Brian Bierie; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-15       Impact factor: 11.205

6.  Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers.

Authors:  Henry Garcia; Jeffrey C Miecznikowski; Alfiya Safina; Mairead Commane; Anja Ruusulehto; Sami Kilpinen; Robert W Leach; Kristopher Attwood; Yan Li; Seamus Degan; Angela R Omilian; Olga Guryanova; Olympia Papantonopoulou; Jianmin Wang; Michael Buck; Song Liu; Carl Morrison; Katerina V Gurova
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

7.  The regulation of SOX7 and its tumor suppressive role in breast cancer.

Authors:  Daniel B Stovall; Meimei Wan; Lance D Miller; Paul Cao; Dejan Maglic; Qiang Zhang; Martha R Stampfer; Wennuan Liu; Jianfeng Xu; Guangchao Sui
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

8.  TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.

Authors:  T N Pathiraja; K N Thakkar; S Jiang; S Stratton; Z Liu; M Gagea; X Shi; P K Shah; L Phan; M-H Lee; J Andersen; M Stampfer; M C Barton
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

9.  Epigenetic regulation of normal human mammary cell type-specific miRNAs.

Authors:  Lukas Vrba; James C Garbe; Martha R Stampfer; Bernard W Futscher
Journal:  Genome Res       Date:  2011-08-26       Impact factor: 9.043

10.  Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine.

Authors:  Yoko S DeRose; Keith M Gligorich; Guoying Wang; Ann Georgelas; Paulette Bowman; Samir J Courdy; Alana L Welm; Bryan E Welm
Journal:  Curr Protoc Pharmacol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.